Relationship between genotypes and serotypes of genogroup 1 recoviruses: a model for human norovirus antigenic diversity.
Human norovirus (NoV) research greatly relies on cell culture-propagable surrogate caliciviruses, including murine NoVs and the prototype 'recovirus' (ReCV), Tulane virus. However, the extreme biological diversity of human NoVs cannot be modelled by a uniform group of viruses or single isolate. Based on a diverse group of recently described ReCVs, a more advanced model reflecting human NoV biological diversity is currently under development. Here, we have reported the genotypic and serotypic relationships among 10 G1 ReCV isolates, including Tulane virus and nine other recent cell culture-adapted strains. Based on the amino acid sequences of virus capsid protein, VP1, and classification constraints established for NoVs, G1 ReCVs were separated into three genotypes, with variable organization of the three open reading frames. Interestingly, cross-neutralization plaque assays revealed the existence of four distinct serotypes, two of which were detected among the G1.2 strains. The amino acid (aa) difference between the two G1.2 ReCV serotypes (12%) was less than the minimum 13% difference established between NoV genotypes. Interestingly, one of the G1.3 ReCVs was equally neutralized by antisera raised against the G1.3 (6% aa difference) and G1.1 (25% aa difference) representative strains. These results imply the existence of a large number of human NoV serotypes, but also shared cross-neutralization epitopes between some strains of different genotypes. In conclusion, the newly developed ReCV surrogate model can be applied to address biologically relevant questions pertaining to enteric CV diversity.
University of Cincinnati College of Medicine, Cincinnati, OH, USA.|Cincinnati Children's Hospital Medical Center, OH, USA.
Tibor
T
Farkas
Cincinnati Children's Hospital Medical Center, OH, USA.
Cindy Wong Ping
CWP
Lun
Cincinnati Children's Hospital Medical Center, OH, USA.
Brittney
B
Fey
D000818:Animals; D000940:Antigenic Variation; D000956:Antigens, Viral / Q000235:genetics* / Q000276:immunology*; D002139:Caliciviridae / Q000235:genetics* / Q000276:immunology*; D036022:Capsid Proteins / Q000235:genetics* / Q000276:immunology*; D016000:Cluster Analysis; D003429:Cross Reactions; D005260:Female; D005838:Genotype; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D010802:Phylogeny; D012367:RNA, Viral / Q000235:genetics; D017422:Sequence Analysis, DNA; D012703:Serotyping; D010948:Viral Plaque Assay
D000956:Antigens, Viral; D036022:Capsid Proteins; D012367:RNA, Viral